Related Experiment Videos
IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets
Trends in Immunology
|August 29, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
EBV reactivation and immunoparalysis indicate a harmful immune endotype in sepsis.
Critical care (London, England)·2026
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
A comprehensive, tri-national, cross-sectional analysis of characteristics and impact of pruritus in psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Prevalence and factors associated with sleep disturbance in adult patients with psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Erythropoietin impacts immune adaptation through myeloid-cell programming.
Trends in immunology·2026
Dendritic cells as programmable platforms for cancer immunotherapy.
Trends in immunology·2026
Spatially instructed checkpoints in antitumor NK cell immunity.
Trends in immunology·2026
Eating to heal: dietary interventions as emerging immune-based therapeutic strategies.
Trends in immunology·2026
Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery.
Trends in immunology·2026
Tracking tumor and immune remodeling through myeloma therapy.
Trends in immunology·2026